Anlon Healthcare share news and announcements
NSE: AHCLBSE: 544497Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹24.35.
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,359 Cr1,681st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 Jul 2026
- 46.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 6.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 30 Jul 2026
- 13.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 30 Jul 2026
- 18.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.22
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 67,35,80547.9% delivered
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Anlon Healthcare quarterly results
The board met on 30 Jul 2026 to consider financial results and other business matters
Notice filed 27 Jul 2026
Anlon Healthcare annual reports, presentations and earnings calls
The company's own documents, latest first.Anlon Healthcare financials, year by year
Annual reports2
Investor presentations4
- Investor Presentation (opens in a new tab)5 Aug 2026
- Investor Presentation (opens in a new tab)3 Jun 2026
- Investor Presentation (opens in a new tab)19 Feb 2026
- Investor Presentation (opens in a new tab)19 Nov 2025
Earnings calls8
- Transcript (opens in a new tab)12 Aug 2026
- Link of Recording (opens in a new tab)6 Aug 2026
- Transcript (opens in a new tab)9 Jun 2026
- Link of Recording (opens in a new tab)3 Jun 2026
- Transcript (opens in a new tab)24 Feb 2026
3 earlier call documents
- Link of Recording (opens in a new tab)19 Feb 2026
- Transcript (opens in a new tab)24 Nov 2025
- Link of Recording (opens in a new tab)19 Nov 2025
Anlon Healthcare share news and announcements
94 announcements, routine notices left out, newest first. Page 1 of 2.
Oct 2026
13 Oct · Board meeting
Sep 2026
29 Sep · Board meeting
21 Sep · Disclosure of material issue
21 Sep · Disclosure of material issue
17 Sep · Legal
The exchange asked on 16 Sep 2026
15 Sep · Rating
Aug 2026
13 Aug · Board meeting
8 Aug · Business
6 Aug · Board meeting
Jul 2026
31 Jul · Analysts
1 Jul · Board meeting
Jun 2026
May 2026
28 May · Analysts
Apr 2026
16 Apr · Business
16 Apr · Board meeting
15 Apr · Rating
9 Apr · Amendment to AOA/MOA
9 Apr · Corporate action
Mar 2026
18 Mar · Analysts
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts).
- 15 Sep 2026Credit ratingup 3.12%+4.8 pts vs Nifty 500market median 0.0% · five sessions +34.1% (+34.1 pts vs Nifty 500) · volume 12.7× usual · delivery −31.3 pts against usual · The announcement (opens in a new tab)
- 16 Apr 2026Credit ratingup 1.76%+1.5 pts vs Nifty 500market median 0.0% · five sessions +4.0% (+2.3 pts vs Nifty 500) · volume 1.4× usual · delivery −9.0 pts against usual · The announcement (opens in a new tab)
- 11 Nov 2025Resultsup 2.28%+1.9 pts vs Nifty 500market median −0.7% · five sessions +5.3% (+3.8 pts vs Nifty 500) · volume 1.2× usual · The announcement (opens in a new tab)
Anlon Healthcare results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Share capital | Year to date to Dec 2025 | Standalone | 5,31,515.00 | 0.53 | −100.0% | 9 Feb 2026 (opens in a new tab) | 1 May 2026 (opens in a new tab) |
| Share capital | Quarter to Dec 2025 | Standalone | 5,31,515.00 | 0.53 | −100.0% | 9 Feb 2026 (opens in a new tab) | 1 May 2026 (opens in a new tab) |
| Earnings per share | Quarter to Jun 2025 | Standalone | 2.22 | 4.44 | +100.0% | 11 Nov 2025 (opens in a new tab) | 13 Apr 2026 (opens in a new tab) |
| Diluted earnings per share | Quarter to Jun 2025 | Standalone | 2.22 | 4.44 | +100.0% | 11 Nov 2025 (opens in a new tab) | 13 Apr 2026 (opens in a new tab) |